Criticizes the Society of Obstetricians and Gynaecologists countering of a CBC documentary on the acne treatment Diane-35 (cyproterone/estradiol). Presents information that supports the concerns regarding the safety of Diane-35.
Discusses an article regarding important safety concerns on the use of cyproterone acetate (marketed as Diane-35 in Canada, and as Dianette in the United Kingdom).
Discusses warnings regarding the drug, Diane-35, and the drug's risk of venous thromboembolism. States that Diane-35 should be reserved for temporary use in women with serious acne and should not be used solely as an oral contraceptive.
Provides training modules designed to meet the continuing educational needs of family planning practitioners, program managers, and policymakers in resource-constrained settings.
